Some studies have indicated that PD patients with LRRK2 gene mutations have a higher risk of developing colorectal cancer (Wang et al., 2024), which contradicts research that does not take PD subtypes into account (Fang et al., 2021). Here, LRRK2 is linked to Parkinson disease.